The Difference of Cell Death Biomarker M65 at Difference Liver Fibrosis Stages of Chronic Hepatitis B

Wei Xinhuan,Ma Lixia,Fan Zuopeng,Liang Shan,Qiu Lixia,Nie Wei,Lin Wei,Liu Yirong,Zheng Sujun,Wei Hongshan,Zhang Jing

DOI: https://doi.org/10.3760/cma.j.issn.1673-4092.2017.06.001

2017-01-01

International Journal of Virology

Abstract:Objective The markers of cell death,M65 and M30,have been suggested to be sensitive markers of liver fibrosis in nonalcoholic fatty liver disease and chronic hepatitis C.Only few studies were carried out on chronic hepatitis B (CHB) and the results were inconsistent.Our aim was to investigate if these markers showed difference in different stages of fibrosis in CHB patients.Methods We examined 186 patients with CHB.Eighteen gender and age matched healthy subjects were used as controls.Blood samples were collected from CHB patients one week before or after liver biopsy.Liver inflammation was graded from G1 to G4,and fibrosis was staged from S1 to S4.The serum levels of M65 and M30 were quantitatively measured using the M65 EpiDeath(R) ELISA kit and the M30 Apoptosense(R) ELISA kit according to the manufacturer's protocol.Results The median level of serum M65 in S2 and cS3 groups were 246.7U/L and 226.5U/L,respectively,and both were higher than that in S1 group (199.6U/L) and in control group (144.5U/L).Conclusions Serum M65 increased with the degree of liver fibrosis and maybe a potential indicator of liver of fibrosis.